RekrutujeFaza III
A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Participants With Previously Untreated Diffuse…
Miasta: Gliwice, Katowice, Lublin, Olsztyn i 3 inne miastaWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
RekrutujeFaza III
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously…
Miasta: Bydgoszcz, Gdańsk, Kraków, Lublin i 6 innych miastWiek: od 18 latSponsor: Regeneron Pharmaceuticals
RekrutujeFaza II/III
International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma
Miasta: WarszawaWiek: do 64 latSponsor: University Medical Center Hamburg-Eppendorf